313 results
8-K
EX-99.1
HRTX
Heron Therapeutics, Inc.
6 Aug 24
Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
4:05pm
of product sales
Gross Profit
Operating expenses:
Research and development
General and administrative
Sales and marketing
Total operating expenses
Loss from
8-K
EX-99.1
HRTX
Heron Therapeutics, Inc.
7 May 24
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
8:05am
of product sales
Gross profit
Operating expenses:
Research and development
General and administrative
Sales and marketing
Total operating expenses
Loss
8-K
EX-99.1
mi0czjs
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
8-K
EX-99.1
1swra ep8u
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
424B3
ugn8o
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
o7eh3a pzg
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-99.2
hh13sf g7p
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-10.1
6eyutljd9
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
kwqu1u8t 07v0
12 Jun 23
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
9:10am
8-K
EX-99.1
w3ofjw z6wc
11 May 23
Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million, Compared to First Quarter Net Product Sales in 2022
4:06pm